Zivanovic et al used a nomogram to predict 5-year survival in a woman following resection of a uterine leiomyosarcoma. This can help to identify a patient who may benefit from a more aggressive or novel therapy. The authors are from Memorial Sloan-Kettering Cancer Center in New York City.
Parameters:
(1) age at diagnosis
(2) tumor diameter in cm
(3) tumor grade
(4) cervical involvement
(5) loco-regional metastases
(6) distant metastases
(7) mitotic index (mitoses in 10 high power fields or hpf; analyzed using log transformation)
points for age in years =
= (0.12 * (age)) - 2.4
points for tumor diameter in cm =
= MIN(28, (diameter in cm))
Mitotic Index |
Points |
---|---|
1 to 4 |
(9.14 * (index)) - 9.1 |
4 to 20 |
(-0.0734 * ((index)^2)) + (3.446 * (index)) + 15.16 |
20 to 148 |
(-0.001962 * ((index)^2)) + (0.6013 * (index)) + 44.79 |
148 to 245 |
(0.103 * (index)) + 74.74 |
Parameter |
Finding |
Points |
---|---|---|
tumor grade |
not high |
0 |
|
high grade |
66 |
cervical involvement |
no |
0 |
|
yes |
15 |
loco-regional metastases |
no |
0 |
|
yes |
56.5 |
distant metastases |
no |
0 |
|
yes |
39 |
total score =
= SUM(points for all 7 parameters)
Interpretation:
• minimum score: 0
• maximum: up to 300
• The higher the score the worse the 5-year survival.
Total Score |
Probability of 5-Year Survival |
---|---|
< 55 |
> 80% |
55 to 152 |
(-0.001468 * ((score)^2)) - (0.1068 * (score)) + 90.24 |
152 to 234 |
(0.002147 * ((score)^2)) - (1.256 * (score)) + 181.4 |
> 234 |
< 5% |
Purpose: To predict the 5-year survival for a woman with a uterine leiomyosarcoma based on the study of Zivanovic et al.
Specialty: Hematology Oncology, Surgery, general, Obstetrics & Gynecology
Objective: severity, prognosis, stage
ICD-10: C54,